Teresa A Pigott

Summary

Affiliation: University of Florida
Country: USA

Publications

  1. ncbi Anxiety disorders in women
    Teresa A Pigott
    Clinical Trials Division, Department of Psychiatry, University of Florida College of Medicine, L4 100, PO Box 100256, Gainesville, FL 32611 0256, USA
    Psychiatr Clin North Am 26:621-72, vi-vii. 2003
  2. ncbi Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study
    Teresa A Pigott
    Department of Psychiatry, University of Florida, UF Brain Institute L4 100, P O Box 100256, Gainesville, FL 32610 0256, USA
    J Clin Psychiatry 64:1048-56. 2003
  3. ncbi Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder
    Teresa A Pigott
    Department of Psychiatry, University of Florida, Gainesville, FL, USA
    Curr Med Res Opin 23:1303-18. 2007

Detail Information

Publications3

  1. ncbi Anxiety disorders in women
    Teresa A Pigott
    Clinical Trials Division, Department of Psychiatry, University of Florida College of Medicine, L4 100, PO Box 100256, Gainesville, FL 32611 0256, USA
    Psychiatr Clin North Am 26:621-72, vi-vii. 2003
    ....
  2. ncbi Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study
    Teresa A Pigott
    Department of Psychiatry, University of Florida, UF Brain Institute L4 100, P O Box 100256, Gainesville, FL 32610 0256, USA
    J Clin Psychiatry 64:1048-56. 2003
    ..This study investigated the efficacy, safety, and tolerability of aripiprazole in preventing relapse in adult chronic schizophrenia patients experiencing ongoing stable symptomatology...
  3. ncbi Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder
    Teresa A Pigott
    Department of Psychiatry, University of Florida, Gainesville, FL, USA
    Curr Med Res Opin 23:1303-18. 2007
    ..The current paper focuses on the longer-term (8-month) comparisons of efficacy and safety between duloxetine and escitalopram...